Erasmus School of Health Policy & Management
Assistant professor | Health Economics (HE)
- reckers@eshpm.eur.nl
More information
Work
- Vivian Reckers-Droog, Joost Enzing & Werner Brouwer (2025) - The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision‑makers and pharmaceutical industry representatives - The European Journal of Health Economics - doi: 10.1007/s10198-025-01771-w
- Stefan Lipman & Vivian Reckers-Droog (2024) - Comparing heuristic valuation processes between health state valuation from child and adult perspectives - The European Journal of Health Economics, 25 (8), 1345-1360 - doi: 10.1007/s10198-023-01668-6 - [link]
- Vivian Reckers-Droog, Joost Enzing & Werner Brouwer (2024) - The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands - HEPAC Health Economics in Prevention and Care, 25 (8), 1449-1459 - doi: 10.1007/s10198-024-01673-3 - [link]
- Anne de Bruijn, Mats van Don, Saskia Knies, Werner Brouwer & Vivian Reckers-Droog (2024) - Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision - PharmacoEconomics, 42 (8), 879-894 - doi: 10.1007/s40273-024-01386-8 - [link]
- Philipa Mos & Vivian Reckers-Droog (2024) - Examining the underpinnings of decisions to allocate public resources to social care:: A systematic review - Social Science and Medicine, 355 - doi: 10.1016/j.socscimed.2024.117093 - [link]
- Vivian Reckers-Droog, Lucas Goossens, Job van Exel & Werner Brouwer (2024) - Societal preferences for granting orphan drugs special status in reimbursement decisions - Health Policy and Technology, 13 (2) - doi: 10.1016/j.hlpt.2024.100870 - [link]
- Leona Hakkaart - van Roijen, Stijn Peeters, Tim Kanters, Pieter van Baal, Werner Brouwer, Ruben Drost, Silvia M.A.A. Evers, Job van Exel, Vivian Reckers-Droog, Nasr-Eddine Tannaoui, Frederick Thielen & Ben Wijnen (2024) - <b>Kostenhandleiding </b>voor economische evaluaties in de gezondheidszorg:: Methodologie en Referentieprijzen - [link]
- Saskia Schawo, Renske Hoefman, Vivian Reckers-Droog, Liesbet Lawerman-van de Wetering, Yifrah Kaminer, Werner Brouwer & Leona Hakkaart-van Roijen (2023) - Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment - European Journal of Health Economics, 25 (5), 903-913 - doi: 10.1007/s10198-023-01633-3 - [link]
- Charlotte Dieteren, Nathalie Patty, Vivian Reckers-Droog & Job van Exel (2023) - Methodological choices in applications of Q methodology: A systematic literature review - Social Sciences and Humanities Open, 7 (1) - doi: 10.1016/j.ssaho.2023.100404 - [link]
- Michael Drummond, Carlo Federici, Vivian Reckers-Droog, Aleksandra Torbica, Carl Rudolf Blankart, Oriana Ciani, Zoltán Kaló, Sándor Kovács & Werner Brouwer (2022) - Coverage with evidence development for medical devices in Europe: Can practice meet theory? - Health Economics (United Kingdom), 31 (S1), 179-194 - doi: 10.1002/hec.4478 - [link]
- Michael Drummond, Carlo Federici, Vivian Reckers‐Droog, Aleksandra Torbica, Carl Rudolf Blankart, Oriana Ciani, Zoltán Kaló, Sándor Kovács & Werner Brouwer (2022) - Coverage with evidence development for medical devices in Europe: Can practice meet theory? - Health Economics, 31 (S1), 179-194 - doi: 10.1002/hec.4478
- Sandor Kovács, Zoltán Kaló, Rita Daubner-Bendes, Katarzyna Kolasa, Rok Hren, Tomas Tesar, Vivian Reckers-Droog, Werner Brouwer, Carlo Federici, Mike Drummond & Antal Tamás Zemplényi (2022) - Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries - Health Economics (United Kingdom), 31 (S1), 195-206 - doi: 10.1002/hec.4504 - [link]
- Vivian Reckers-Droog, Milad Karimi, Stefan Lipman & Janine Verstraete (2022) - Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study - Value in Health, 25 (7), 1174-1184 - doi: 10.1016/j.jval.2021.12.014 - [link]
- Charlotte Dieteren, Vivian Reckers, Sara Schrama, Dynothra de Boer & Job van Exel (2022) - Viewpoints among experts and the public in the Netherlands on including a lifestyle criterion in the healthcare prioritysetting - Health Expectations, 25 (1), 333-344 - doi: 10.1111/hex.13385 - [link]
- Vivian Reckers-Droog, Leona Hakkaart - van Roijen & Y Kaminer (2022) - The Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): Features and Applications - doi: 10.1007/978-3-030-92392-1_178 - [link]
- S. A. Lipman, V. T. Reckers-Droog, M. Karimi, M. Jakubczyk & A. E. Attema (2021) - Self vs. other, child vs. adult.: An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states - European Journal of Health Economics, 22 (9), 1507-1518 - doi: 10.1007/s10198-021-01377-y - [link]
- Vivian Reckers-Droog, NJA van Exel & Werner Brouwer (2021) - Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients - Value in Health - doi: 10.1016/j.jval.2021.01.012 - [link]
- Stefan Lipman, Vivian Reckers - Droog & S Kreimeier (2021) - Think of the Children: A Discussion of the Rationale for and Implications of the Perspective Used for EQ-5D-Y Health State Valuation - Value in Health, 24 (7), 976-982 - doi: 10.1016/j.jval.2021.01.011 - [link]
- Carlo Federici, Vivian Reckers-Droog, Oriana Ciani, Florian Dams, Bogdan Grigore, Zoltán Kaló, Sándor Kovács, Kosta Shatrov, Werner Brouwer & Michael Drummond (2021) - Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges - European Journal of Health Economics, 22 (8), 1253-1273 - doi: 0.1007/s10198-021-01334-9 - [link]
- Vivian Reckers (2022) - Frans Rutten Research Award 2022
- Vivian Reckers (2019) - European Cooperation on Healthcare (FPM conference): Poster prize
ZonMW
- Start date approval
- november 2024
- End date approval
- november 2027
- Place
- DEN HAAG
- Description
- Member ZonMW committee Evaluatie Effecten en Koste
